ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,268 | -18.0% | 84,553 | +9.2% | 0.01% | -28.6% |
| Q2 2023 | $2,766 | +30.5% | 77,417 | -7.2% | 0.01% | +40.0% |
| Q1 2023 | $2,119 | -26.5% | 83,421 | +17.3% | 0.01% | -37.5% |
| Q4 2022 | $2,883 | -99.9% | 71,130 | +11.4% | 0.01% | +33.3% |
| Q3 2022 | $2,109,000 | -7.7% | 63,827 | -1.6% | 0.01% | 0.0% |
| Q2 2022 | $2,284,000 | -15.4% | 64,892 | +13.5% | 0.01% | 0.0% |
| Q1 2022 | $2,699,000 | -21.9% | 57,154 | +9.4% | 0.01% | -14.3% |
| Q4 2021 | $3,457,000 | +12.3% | 52,255 | +6.8% | 0.01% | 0.0% |
| Q3 2021 | $3,078,000 | -7.2% | 48,916 | +22.1% | 0.01% | -12.5% |
| Q2 2021 | $3,318,000 | +25.8% | 40,075 | +0.6% | 0.01% | +33.3% |
| Q1 2021 | $2,638,000 | -20.0% | 39,836 | -7.3% | 0.01% | 0.0% |
| Q4 2020 | $3,298,000 | +59.7% | 42,993 | -10.5% | 0.01% | +50.0% |
| Q3 2020 | $2,065,000 | -13.8% | 48,050 | -13.5% | 0.00% | -20.0% |
| Q2 2020 | $2,396,000 | +55.5% | 55,542 | +3.8% | 0.01% | +25.0% |
| Q1 2020 | $1,541,000 | -48.9% | 53,518 | +11.7% | 0.00% | -42.9% |
| Q4 2019 | $3,017,000 | -10.6% | 47,920 | -62.4% | 0.01% | -12.5% |
| Q2 2019 | $3,376,000 | +1477.6% | 127,402 | +989.1% | 0.01% | +700.0% |
| Q1 2019 | $214,000 | +130.1% | 11,698 | +50.3% | 0.00% | – |
| Q4 2018 | $93,000 | -37.6% | 7,782 | 0.0% | 0.00% | – |
| Q3 2018 | $149,000 | +40.6% | 7,782 | 0.0% | 0.00% | – |
| Q2 2018 | $106,000 | +863.6% | 7,782 | +36.5% | 0.00% | – |
| Q1 2017 | $11,000 | +22.2% | 5,700 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | -89.3% | 5,700 | -50.0% | 0.00% | – |
| Q3 2016 | $84,000 | +180.0% | 11,400 | +100.0% | 0.00% | – |
| Q2 2016 | $30,000 | – | 5,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |